Cargando…

Longitudinal changes in personalized platelet count metrics are good indicators of initial 3-year outcome in colorectal cancer

BACKGROUND: Platelet count or complete blood count (CBC)-based ratios including lymphocyte-to-monocyte (LMR), neutrophil-to-lymphocyte (NLR), hemoglobin-to-platelet (HPR), red blood cell count distribution width-to-platelet (RPR), and platelet-to-lymphocyte (PLR) ratio are good predictors of colorec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Herold, Zoltan, Herold, Magdolna, Lohinszky, Julia, Szasz, Attila Marcell, Dank, Magdolna, Somogyi, Aniko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297428/ https://www.ncbi.nlm.nih.gov/pubmed/36051133 http://dx.doi.org/10.12998/wjcc.v10.i20.6825

Ejemplares similares

Personalized Indicator Thrombocytosis Shows Connection to Staging and Indicates Shorter Survival in Colorectal Cancer Patients with or without Type 2 Diabetes
por: Herold, Zoltan, et al.
Publicado: (2020)

High plasma CD40 ligand level is associated with more advanced stages and worse prognosis in colorectal cancer
por: Herold, Zoltan, et al.
Publicado: (2022)

Comparison of the effectiveness of integrative immunomodulatory treatments and conventional therapies on the survival of selected gastrointestinal cancer patients
por: Kleef, Ralf, et al.
Publicado: (2023)

Longitudinal Analysis of 1α,25-dihidroxyvitamin D(3) and Homocysteine Changes in Colorectal Cancer
por: Mühl, Dorottya, et al.
Publicado: (2022)

Does Elevated Pre-Treatment Plasma PD-L1 Level Indicate an Increased Tumor Burden and Worse Prognosis in Metastatic Colorectal Cancer?
por: Dank, Magdolna, et al.
Publicado: (2022)

Influence of the duration of type 2 diabetes mellitus on colorectal cancer outcomes
por: Herold, Magdolna, et al.
Publicado: (2023)

Prolonged hyperthermic intraperitoneal chemotherapy duration with 90 minutes cisplatin might increase overall survival in gastric cancer patients with peritoneal metastases
por: Steinhoff, Heinrich, et al.
Publicado: (2023)

Evidence based tools to improve efficiency of currently administered oncotherapies for tumors of the hepatopancreatobiliary system
por: Herold, Zoltan, et al.
Publicado: (2021)

Histopathological Chromogranin A-Positivity Is Associated with Right-Sided Colorectal Cancers and Worse Prognosis
por: Herold, Zoltan, et al.
Publicado: (2020)

Meta-Analysis of Modulated Electro-Hyperthermia and Tumor Treating Fields in the Treatment of Glioblastomas
por: Szasz, Attila Marcell, et al.
Publicado: (2023)

Does diabetes affect paraneoplastic thrombocytosis in colorectal cancer?
por: Herczeg, Gyorgy, et al.
Publicado: (2022)

High Tumor-Infiltrating Lymphocyte Count Is Associated with Distinct Gene Expression Profile and Longer Patient Survival in Advanced Ovarian Cancer
por: Barna, Andras Jozsef, et al.
Publicado: (2023)

Modulated Electro-Hyperthermic (mEHT) Treatment in the Therapy of Inoperable Pancreatic Cancer Patients—A Single-Center Case-Control Study
por: Petenyi, Flora Greta, et al.
Publicado: (2021)

Serum chromogranin A level continuously rises with the progression of type 1 diabetes, and indicates the presence of both enterochromaffin‐like cell hyperplasia and autoimmune gastritis
por: Herold, Zoltan, et al.
Publicado: (2020)

Patients with Metachronous Peritoneal Metastatic Mucinous Colorectal Adenocarcinoma Benefit More from Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) than Their Synchronous Counterparts
por: Herold, Zoltan, et al.
Publicado: (2022)

Lower serum chromogranin B level is associated with type 1 diabetes and with type 2 diabetes patients with intensive conservative insulin treatment
por: Herold, Zoltan, et al.
Publicado: (2020)

The Prediction Analysis of Microarray 50 (PAM50) Gene Expression Classifier Utilized in Indeterminate-Risk Breast Cancer Patients in Hungary: A Consecutive 5-Year Experience
por: Dank, Magdolna, et al.
Publicado: (2023)

New therapeutic approaches for type 1 diabetes: Disease-modifying therapies
por: Nagy, Geza, et al.
Publicado: (2022)

Correlation between Expression Profiles of Key Signaling Genes in Colorectal Cancer Samples from Type 2 Diabetic and Non-Diabetic Patients
por: Elek, Zsuzsanna, et al.
Publicado: (2020)

Deconstructing Immune Cell Infiltration in Human Colorectal Cancer: A Systematic Spatiotemporal Evaluation
por: Ágoston, Emese Irma, et al.
Publicado: (2022)

Morphological and pathological response in primary systemic therapy of patients with breast cancer and the prediction of disease free survival: a single center observational study
por: Szentmártoni, Gyöngyvér, et al.
Publicado: (2016)

Review of the Clinical Evidences of Modulated Electro-Hyperthermia (mEHT) Method: An Update for the Practicing Oncologist
por: Szasz, Attila M., et al.
Publicado: (2019)

Role and function of granin proteins in diabetes mellitus
por: Herold, Zoltan, et al.
Publicado: (2021)

Prolonged Exposition with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) May Provide Survival Benefit after Cytoreductive Surgery (CRS) in Advanced Primary Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
por: Acs, Miklos, et al.
Publicado: (2022)

Significance of platelet count in children admitted with bronchiolitis
por: Al Shibli, Amar, et al.
Publicado: (2017)

Dynamic FDG-PET/CT in the Initial Staging of Primary Breast Cancer: Clinicopathological Correlations
por: Kajáry, Kornélia, et al.
Publicado: (2019)

Quantitative PCR from human genomic DNA: The determination of gene copy numbers for congenital adrenal hyperplasia and RCCX copy number variation
por: Doleschall, Márton, et al.
Publicado: (2022)

Ratio of mean platelet volume to platelet count is a potential surrogate marker predicting liver cirrhosis
por: Iida, Hiroya, et al.
Publicado: (2018)

Low platelet count: Predictor of death and graft loss after liver transplantation
por: Beltrame, Pedro, et al.
Publicado: (2019)

Opposite prognostic roles of HIF1α and HIF2α expressions in bone metastatic clear cell renal cell cancer
por: Szendrői, Attila, et al.
Publicado: (2016)

Methyl Donors Reduce Cell Proliferation by Diminishing Erk-Signaling and NFkB Levels, While Increasing E-Cadherin Expression in Panc-1 Cell Line
por: Kiss, Eva, et al.
Publicado: (2022)

Pre-treatment platelet counts as a prognostic and predictive factor in stage II and III rectal adenocarcinoma
por: Steele, Morgan, et al.
Publicado: (2017)

Changes in the cochlear and retrocochlear parts of the auditory system in 19–39 and 40–60 years old patients with type 1 diabetes mellitus
por: Horváth, Mihály, et al.
Publicado: (2023)

Successful treatment of three synchronous primary malignant tumours—reflection on surgical, pathological and oncological aspects and decision making
por: Ágoston, Emese Irma, et al.
Publicado: (2018)

Platelet count as a screening tool for compensated cirrhosis in chronic viral hepatitis
por: Surana, Pallavi, et al.
Publicado: (2021)

Pravastatin in preeclampsia: A meta-analysis and systematic review
por: Mészáros, Balázs, et al.
Publicado: (2023)

Platelet count and platelet indices in women with preeclampsia
por: AlSheeha, Muneera A, et al.
Publicado: (2016)

Methyl-Donors Can Induce Apoptosis and Attenuate Both the Akt and the Erk1/2 Mediated Proliferation Pathways in Breast and Lung Cancer Cell Lines
por: Kiss, Eva, et al.
Publicado: (2021)

The Effect of Dietary Methyl-Donor Intake and Other Lifestyle Factors on Cancer Patients in Hungary
por: Kiss, Eva, et al.
Publicado: (2022)

Combination of type IV collagen 7S, albumin concentrations, and platelet count predicts prognosis of non-alcoholic fatty liver disease
por: Kawanaka, Miwa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qbi920cfq195kcaqmcpgcsndig